Materials and Reagents
1. Prepare 0.01 N acetic acid in ddH2O and filter through a 0.2 µM membrane to sterilize diluent. Store at 4 °C.
2. Dilute 10 mg of bovine collagen with 2.5 ml of 0.01 N acetic acid for a final concentration of 4 mg/ml collagen.
3. Secure lid and wrap the collagen bottle in aluminum foil to avoid light exposure.
4. Rotate the bottle overnight at 4 °C or until collagen is completely dissolved.
5. Aliquot collagen solution (500 µl aliquots) and freeze at -20 °C.
a. Aliquots of collagen can be stored at -20 °C for 6 months.
b. Aliquots should not be thawed more than 2 times prior to injection.
Preparation of anesthetic
6. Prepare a working solution of 25 mg/ml ketamine and 2.5 mg/ml xylazine in PBS.
Store working solution for 2 weeks at room temperature, or 1-3 months at 4 °C. a. For a 10 ml solution, combine 2.5 ml of ketamine stock, and 0.25 ml of xylazine stock, with 7.25 ml PBS. http://www.bio-protocol.org/e1626 Vol 5, Iss 20, Oct 20, 2015 while the second syringe stands at a 90° angle to the syringe with the plunger ( Figure   1A ).
9. Create a working solution of collagen by adding 4 mg/ml collagen stock to 0.01 N acetic acid at a 1:1 ratio in the standing syringe ( Figure 1B ).
10. Add CFA to the syringe at a 1:1 ratio of collagen working solution in the standing syringe.
a. Example: 500 µl 4 mg/ml collagen, 500 µl 0.01 N acetic acid, and 1 ml CFA.
b. Actual volumes of the working solution and CFA will be determined by the number of mice to be immunized, where each DBA/1J mouse receives 0.1 ml of the final emulsion.
c. Mixing the emulsion will cause 0.4 ml of the emulsion to be lost in the stopcock, be sure to account for this when determining volumes of reagents.
11. Turn the stopcock lever to close the valve opening not connected to a syringe.
12. Place the plunger in the standing syringe.
13. Mix the solution between the two syringes slowly, by plunging the entire solution into the opposite syringe 20 times. This will create a white emulsion ( Figure 1C ).
14. Plunge all of the collagen into a single syringe. While holding the syringe containing the collagen stopcock end up ( Figure 1D ), remove the stopcock and connect a 27 gauge ½ inch luer lock needle to the end of the syringe.
15. Gently and slowly lower the plunger to remove air from syringe until the collagen emulsion fills the needle ( Figure 1E ).
16. Place collagen emulsion on ice and away from light until immunization. 21. Mix the collagen slowly, and assemble the needle with the same methods described for day 0 immunization.
22. Anesthetize each mouse with an 0.1 ml injection of the ketamine/xylazine working solution described in step A6a.
23. Place the fully anesthetized mouse in the restraint with tail exposed.
24. Inject 0.1 ml of collagen emulsion into the tail of the mouse closer to the base of the tail than the original injection site.
If the boost injection is administered further from the base of the tail than the original injection spot, arthritis may develop slowly, or to a lesser extent than boost injections given closer to the base of the tail.
B. Collagen-induced arthritis: Immunization of C57BL/6J mice with type II chicken collagen
The procedure to elicit CIA in C57BL/6J mice is modeled after the DBA/1J procedure, but contains two major changes. Immunization of C57BL/6J mice uses type II chicken collagen in place of type II bovine collagen. Additionally, the concentration of MT in CFA is increased to 3-4 mg/ml for C57BL/6J mice from than 1 mg/ml used for DBA/1J mice. All other details are identical to the DBA/1J procedure.
C. Paw measurement and scoring arthritis 1. Anesthetize mice with the drop method of isoflurane anesthesia (add approximately 0.3 ml to a 500 µl container per IACUC guidelines).
2. Weigh each mouse, score paws, and measure paw thickness on day 0 and once a week until day 21. After day 21, weigh, measure and score paws twice a week. a. To measure the front paws, the caliper should touch the back of the paw and the "palm" of the paw (Figure 2A ).
b. To measure the hind paws, the caliper should be placed on either side of the ankle joint, measuring the width of the ankle joint from one side to the other ( Figure 2B ). 2. Display the data in an XY plot, where Y is arthritis score and X is days after immunization ( Figure 3A ).
3. Plot the measurement data by subtracting the thickness of the paw in mm from the original day 0 thickness.
4. Display the data in an XY plot, where Y is swelling in mm and X is days after immunization ( Figure 3B ).
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http://www.bio-protocol.org/e1626 Vol 5, Iss 20, Oct 20, 2015 Representative data Figure 3 . DBA/1J mice were immunized with type II bovine collagen in CFA on day 0, and boosted with type II bovine collagen in IFA on day 21. Over the course of disease, an arthritis score was attributed to each paw of each mouse, based on the features described in section C. The score of each paw was summed for a score of 0-12 for each mouse (A). The thickness of each paw was also measured and the increase in paw thickness in mm was plotted (B). The displayed results represent three individual mice.
